 48%

Question 2: CEA vs CAS in symptomatic patients
Bonati et al,16 2015
Huibers, 201517
Featherstone
et al,18 2016
ICSS,19 2010 (ICSS)
International,
multicenter

(A) 857
(B) 853

(A) 70
(B) 70

Comments

Journal of Vascular Surgery

Hasan et al

108S.e11

Volume 75, Number 1S

Supplementary Table II (online only). Continued.
Author,
year (trial name)
geographic area

Total No. of
patients (A)
CEA (B) CAS

Mean
age, years

Male sex, %

Mean BMI

Comorbidities (CEA)

Comorbidities (CAS)

Brooks et al,20 2001
USA

(A) 51
(B) 53

(A) 69.6
(B) 66.4

NR

NR

HTN 94.1%, DM 23.5%
smoking: 78.4% CAD
60.8%

HTN 84.9%, DM 35.9%,
smoking: 71.7%, CAD
73.6%

Eckstein et al,21
2008
Ringaleb et al,22
200422
Ringaleb et al,23
2006
(SPACE)
Europe,
multicenter

(A) 589
(B) 607

(A) 68.7
(B) 68.1

(A) 72
(B) 72

(A) 26.7
(B) 27.2

HTN 76%, DM 29%, coronary
heart disease 24%,
previous or present
smoker 70%

HTN 75%, DM 26%, coronary
heart disease 21%,
previous or present
smoker 71%

Data mostly from Eckstein
et al,21 2008 and
Ringaleb,